571 - Effects of alcohol use on tenofovir alafenamide metabolites among persons with HIV: Implications from a pharmacokinetic model

Presenting Author(s)

• 

  Sean Avedissian

  Duarte, CA

  Slides

Co-Author(s)

• AD

  Ali Dunbar, PhD

  University of Colorado
  Denver, Colorado, United States
• RP

  Robert B. Parker, Pharm.D.

  Professor
  UTHSC College of Pharmacy
  Memphis, Tennessee, United States
• SL

  Steven Laizure, PharmD

  University of Tennessee
  Memphis, Tennessee, United States
• RC

  Ryan Coyle, BS

  University of Colorado
  Denver, Colorado, United States
• MM

  Mary Morrow, MS

  University of Colorado
  Denver, Colorado, United States
• SM

  Samantha MaWhinney, ScD

  Professor
  Colorado School of Public Health
  Denver, Colorado, United States
• LB

  Lane Bushman, BChem

  University of Colorado Anschutz Medical Campus
  Aurora, Colorado, United States
• LE

  Lucas Ellison, B.S.

  University of Colorado - Anschutz Medical Campus
  Aurora, Colorado, United States
• JZ

  Jia-Hua Zheng, BS

  University of Colorado
  Denver, Colorado, United States
• SA

  Subhi Al-Zuabi, MD, BS

  Professional Research Assistant
  University of Colorado Anschutz Medical Campus
  Aurora, Colorado, United States
• KB

  Kristina Brooks, PharmD

  Assistant Professor
  University of Colorado Anschutz Medical Campus
  Aurora, Colorado, United States
• 

  Ukamaka O. Modebelu, MS (she/her/hers)

  Graduate Research Assistant
  UNMC
  Omaha, NE, United States
• 

  Jose Castillo-Mancilla, MD

  Associate Professor
  University of Colorado-AMC
• PA

  Peter Anderson, PharmD

  Skaggs School of Pharmacy and Pharmaceutical Sciences / University of Colorado Anschutz Medical Campus
  Aurora, Colorado, United States